TP53 and neoplasm: We undertook this analysis to compare and contrast the activity of these two novel compounds and explore the disease specificity, possible mechanisms of action, combinatorial potential and impact of specific TP53 mutations on efficacy using a previously validated 3-D human tumor explant platform.